Precision fermentation is emerging as a disruptive force in the inositol category, bringing a cleaner, more controlled, and sustainable alternative to conventional production methods. Traditionally sourced from corn or wheat byproduct streams through chemical hydrolysis, inositol manufacturing has long faced concerns around impurity profiles, agricultural contaminants, and supply chain variability. New precision-fermented myo-inositol and D-chiro-inositol ingredients are now being produced directly from clean sugar-based substrates, enabling higher consistency, transparency, and purity without compromising bioavailability or functionality. This innovation is particularly relevant for women’s health, prenatal nutrition, metabolic health, and PCOS-focused formulations, where demand for clinically trusted and traceable ingredients continues to rise. As consumers increasingly seek “clean-label” and sustainably produced actives, fermentation-derived inositols may represent the next evolution of science-backed metabolic wellness ingredients.